Access cutting-edge glaucoma treatment through this clinical trial at a research site in Beaumont. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Beaumont location
Preparing your pre-screening questions…
Access glaucoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glaucoma treatment provided free
Check if you qualify for this glaucoma clinical trial in Beaumont, TX
No-Cost Study Care
Local to Beaumont
Convenient for TX residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a randomized, double-masked, single-site, prospective, contralateral eye study designed to evaluate the outcomes of Direct Selective Laser Trabeculoplasty (DSLT) followed by the addition of combination netarsudil and latanoprost (Rocklatan) versus latanoprost monotherapy. The study will be conducted at one investigational site. The primary endpoint is the change in mean diurnal intraocular pressure (IOP) from baseline (post DSLT and post washout) at visit 3 between the two groups. Secondary endpoints include the change in mean IOP from baseline at each timepoint (8am, 12pm, 4pm) at visit 3 between groups, and the mean percentage decrease in IOP from baseline for each group. Assessments will be conducted at three key visits: Visit 1 (Screening Phase and DSLT Procedure on Day 0), Visit 2 (Baseline Visit post washout at Week 8), and Visit 3 (Follow-Up Visit 1 at Week 12). Each visit will include specific examinations and measurements such as visual field and OCT imaging, diurnal IOP measurements, and documentation of adverse events.
Sponsor: Eye Centers of Southeast Texas
Yes, this clinical trial (NCT07465913) has an active research site in Beaumont, TX that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for glaucoma treatment options in Beaumont, TX, this clinical trial (NCT07465913) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Beaumont research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glaucoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all glaucoma clinical trials near you to find additional studies recruiting in your area.
See all ulcerative colitis clinical trials recruiting in Beaumont — not just this study.
Browse Ulcerative Colitis Trials in Beaumont →